Skip to main content
. 2023 May 9;37(8):e24892. doi: 10.1002/jcla.24892

FIGURE 3.

FIGURE 3

Relationship between AK2 and clinicopathological characteristics of glioma patients. (A, F, K) AK2 expression in different WHO grades in TCGA, CGGA325, and CGGA693. (B, G, L) AK2 expression in different age groups in TCGA, CGGA325, and CGGA693. (C, H, M) AK2 expression in different IDH statuses in TCGA, CGGA325, and CGGA693. (D, I, N) AK2 expression in different 1p/19q statuses in TCGA, CGGA325, and CGGA693. (E, J, O) AK2 expression in different MGMT statuses in TCGA, CGGA325, and CGGA693.